Unlike the effect of Foxp3+ Tregs, the role of cytotoxic CD8+ TILs in the setting of RCC has been controversial, with several studies demonstrating conflicting results [10, 18–22]. The gene discussed is FOXP3; the disease is renal cell carcinoma.